Pink Sheet is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Micro-Partnerships With Academia Helping To Drive Bristol’s Pipeline Development

Executive Summary

New agreement with Duke Translational Medicine Institute highlights Bristol-Myers Squibb’s particular approach to collaborating with academia – small, low-money partnerships that get pharma and university scientists working together in an atmosphere virtually free of corporate bureaucracy.

You may also be interested in...



BMS Taps Emory For Clinical Trials In Oncology, Other Areas

Bristol-Myers Squibb forms an alliance with Emory University to conduct mid- and late-stage trials in oncology, metabolics, hepatitis C, and immunoscience using BMS compounds.

Bristol-Myers Taps Academia To Help Research Immuno-Oncology Pipeline

Inspired by the correlative research during the clinical trials for Yervoy, BMS teams up with ten institutions from across the globe to find biomarkers in post-response data.

Merck Ups The Calibr Of Academic-Industry Cooperation

Merck announced March 15 that it plans to invest $90 million over the next seven years in a nonprofit biomedical research center in San Diego dubbed the California Institute for Biomedical Research, or Calibr.

Related Content

Topics

Related Companies

UsernamePublicRestriction

Register

PS054250

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel